Pangaea Oncology SA
MAD:PANG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pangaea Oncology SA
MAD:PANG
|
ES |
|
A
|
AMD Industries Ltd
NSE:AMDIND
|
IN |
|
Emyria Ltd
ASX:EMD
|
AU |
|
P
|
Palo Alto Networks Inc
F:5AP
|
US |
|
Greenfirst Forest Products Inc
TSX:GFP
|
CA |
|
V
|
Visa Inc
BMV:V
|
US |
|
M
|
Miss Grand International PCL
SET:MGI
|
TH |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PANG's stock price target?
Not Available
PANG does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Pangaea Oncology SA?
Projected CAGR
15%
Over the last 12 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 15%.
What is the Gross Profit forecast for Pangaea Oncology SA?
Projected CAGR
27%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 27%.